27688904|t|C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch
27688904|a|The aim of the present study was to describe the association of positive flow cross match (FXM) and C1q-SAB. Methods. In this observational, cross-sectional, and comparative study, patients included had negative AHG-CDC-XM and donor specific antibodies (DSA) and were tested with FXM. All pretransplant sera were tested with C1q-SAB assay. Results. A total of 50 donor / recipient evaluations were conducted; half of them had at least one C1q+ Ab (n = 26, 52%). Ten patients (20.0%) had DSA C1q+ Ab. Twenty-five (50%) FXMs were positive. Factors associated with a positive FXM were the presence of C1q+ Ab (DSA C1q+ Ab: OR 27, 2.80-259.56, P = 0.004, and no DSA C1q+ Ab: OR 5, 1.27-19.68, P = 0.021) and the DSA LABScreen-SAB MFI (OR 1.26, 95% CI 1.06-1.49, P = 0.007). The cutoff point of immunodominant LABScreen SAB DSA - MFI with the greatest sensitivity and specificity to predict FXM was 2,300 (sensitivity: 72% and specificity: 75%). For FXM prediction, DSA C1q+ Ab was the most specific (95.8%, 85-100) and the combination of DSA - MFI > 2,300 and C1q+ Ab was the most sensitive (92.0%, 79.3-100). Conclusions. C1q+ Ab and LABScreen SAB DSA - MFI were significantly associated with FXM. DSA C1q+ Ab was highly specific but with low sensitivity.
27688904	0	9	C1Q Assay	T059	C1167938
27688904	21	54	Complement-Dependent Cytotoxicity	T059	C4084772
27688904	55	65	Crossmatch	T059	C0855279
27688904	66	74	Negative	T033	C0205160
27688904	75	91	Renal Transplant	T061	C0022671
27688904	92	102	Candidates	T098	C1257890
27688904	108	133	Donor-Specific Antibodies	T116,T129	C0003241
27688904	135	139	High	T080	C0205250
27688904	140	151	Specificity	T081	C0037791
27688904	156	159	Low	T080	C0205251
27688904	160	171	Sensitivity	T081	C1511883
27688904	177	187	Predicting	T078	C0681842
27688904	188	203	Flow Crossmatch	T059	C0201644
27688904	253	264	association	T080	C0439849
27688904	268	276	positive	T033	C1446409
27688904	277	293	flow cross match	T059	C0201644
27688904	295	298	FXM	T059	C0201644
27688904	304	311	C1q-SAB	T059	C1167938
27688904	330	343	observational	T062	C1518527
27688904	345	360	cross-sectional	T062	C0010362
27688904	366	383	comparative study	T062	C1579762
27688904	385	393	patients	T101	C0030705
27688904	407	415	negative	T033	C0205160
27688904	416	426	AHG-CDC-XM	T059	C0855279
27688904	431	456	donor specific antibodies	T116,T129	C0003241
27688904	458	461	DSA	T116,T129	C0003241
27688904	484	487	FXM	T059	C0201644
27688904	493	511	pretransplant sera	T031	C0229671
27688904	529	542	C1q-SAB assay	T059	C1167938
27688904	567	572	donor	T098	C0013018
27688904	575	584	recipient	T098	C1709854
27688904	585	596	evaluations	T058	C0220825
27688904	643	650	C1q+ Ab	T116,T129	C1717709
27688904	670	678	patients	T101	C0030705
27688904	691	694	DSA	T116,T129	C0003241
27688904	695	702	C1q+ Ab	T116,T129	C1717709
27688904	722	726	FXMs	T059	C0201644
27688904	732	740	positive	T033	C1446409
27688904	742	749	Factors	T169	C1521761
27688904	750	765	associated with	T080	C0332281
27688904	768	776	positive	T033	C1446409
27688904	777	780	FXM	T059	C0201644
27688904	790	798	presence	T033	C0150312
27688904	802	809	C1q+ Ab	T116,T129	C1717709
27688904	811	814	DSA	T116,T129	C0003241
27688904	815	822	C1q+ Ab	T116,T129	C1717709
27688904	824	826	OR	T081	C0028873
27688904	862	865	DSA	T116,T129	C0003241
27688904	866	873	C1q+ Ab	T116,T129	C1717709
27688904	875	877	OR	T081	C0028873
27688904	912	915	DSA	T116,T129	C0003241
27688904	916	929	LABScreen-SAB	T129	C0078968
27688904	930	933	MFI	T081	C0392762
27688904	935	937	OR	T081	C0028873
27688904	948	950	CI	T081	C0009667
27688904	978	990	cutoff point	T169	C1442160
27688904	994	1022	immunodominant LABScreen SAB	T129	C0078968
27688904	1023	1026	DSA	T116,T129	C0003241
27688904	1029	1032	MFI	T081	C0392762
27688904	1042	1050	greatest	T081	C0205393
27688904	1051	1062	sensitivity	T081	C1511883
27688904	1067	1078	specificity	T081	C0037791
27688904	1082	1089	predict	T078	C0681842
27688904	1090	1093	FXM	T059	C0201644
27688904	1105	1116	sensitivity	T081	C1511883
27688904	1126	1137	specificity	T081	C0037791
27688904	1149	1152	FXM	T059	C0201644
27688904	1153	1163	prediction	T078	C0681842
27688904	1165	1168	DSA	T116,T129	C0003241
27688904	1169	1176	C1q+ Ab	T116,T129	C1717709
27688904	1185	1189	most	T081	C0205393
27688904	1190	1198	specific	T080	C0205369
27688904	1238	1241	DSA	T116,T129	C0003241
27688904	1244	1247	MFI	T081	C0392762
27688904	1260	1267	C1q+ Ab	T116,T129	C1717709
27688904	1276	1280	most	T081	C0205393
27688904	1281	1290	sensitive	T169	C0332324
27688904	1323	1330	C1q+ Ab	T116,T129	C1717709
27688904	1335	1348	LABScreen SAB	T129	C0078968
27688904	1349	1352	DSA	T116,T129	C0003241
27688904	1355	1358	MFI	T081	C0392762
27688904	1378	1393	associated with	T080	C0332281
27688904	1394	1397	FXM	T059	C0201644
27688904	1399	1402	DSA	T116,T129	C0003241
27688904	1403	1410	C1q+ Ab	T116,T129	C1717709
27688904	1422	1430	specific	T080	C0205369
27688904	1440	1443	low	T080	C0205251
27688904	1444	1455	sensitivity	T081	C1511883